Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CCM NASDAQ:DCGO NASDAQ:EUDA NASDAQ:SERA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCMConcord Medical Services$4.74-6.4%$4.37$3.18▼$10.77$21.97M-0.9943,879 shs65,422 shsDCGODocGo$0.56-1.9%$0.61$0.49▼$1.78$56.30M1604,221 shs600,789 shsEUDAEUDA Health$16.06-1.5%$12.37$5.26▼$86.00$48.84M0.6411,673 shs5,150 shsSERASera Prognostics$2.29+2.2%$2.02$1.37▼$4.09$87.91M0.9481,637 shs33,596 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCMConcord Medical Services+7.89%-0.69%+2.77%+28.05%-34.77%DCGODocGo-0.73%-13.27%-16.63%-15.15%-60.41%EUDAEUDA Health-2.63%-13.11%0.00%+11.71%-74.36%SERASera Prognostics+9.27%+4.67%+19.15%+14.87%+31.76%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCMConcord Medical Services$4.74-6.4%$4.37$3.18▼$10.77$21.97M-0.9943,879 shs65,422 shsDCGODocGo$0.56-1.9%$0.61$0.49▼$1.78$56.30M1604,221 shs600,789 shsEUDAEUDA Health$16.06-1.5%$12.37$5.26▼$86.00$48.84M0.6411,673 shs5,150 shsSERASera Prognostics$2.29+2.2%$2.02$1.37▼$4.09$87.91M0.9481,637 shs33,596 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCMConcord Medical Services+7.89%-0.69%+2.77%+28.05%-34.77%DCGODocGo-0.73%-13.27%-16.63%-15.15%-60.41%EUDAEUDA Health-2.63%-13.11%0.00%+11.71%-74.36%SERASera Prognostics+9.27%+4.67%+19.15%+14.87%+31.76%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCCMConcord Medical Services 1.00SellN/AN/ADCGODocGo 2.33Hold$2.38324.71% UpsideEUDAEUDA Health 2.00Hold$55.00242.47% UpsideSERASera Prognostics 2.67Moderate Buy$5.50140.17% UpsideCurrent Analyst Ratings BreakdownLatest CCM, SERA, DCGO, and EUDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/4/2026SERASera Prognostics Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$6.005/26/2026CCMConcord Medical Services Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/11/2026DCGODocGo Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/8/2026EUDAEUDA Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (E+)5/8/2026EUDAEUDA Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/8/2026EUDAEUDA Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)3/27/2026SERASera Prognostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/25/2026DCGODocGo Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$1.50 ➝ $1.003/23/2026EUDAEUDA Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/17/2026DCGODocGo Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$4.00 ➝ $2.503/17/2026DCGODocGo Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$3.00(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCCMConcord Medical Services$65.85M0.31$1.74 per share2.72$60.94 per share0.08DCGODocGo$322.20M0.17$0.05 per share10.30$1.28 per share0.44EUDAEUDA Health$6.82M7.04N/AN/A($2.26) per share-7.11SERASera Prognostics$80K1,120.96N/AN/A$1.94 per share1.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCCMConcord Medical Services-$13.27MN/AN/AN/AN/AN/AN/AN/AN/ADCGODocGo-$182.40M-$1.91N/A11.18N/A-62.23%-44.09%-29.14%8/6/2026 (Estimated)EUDAEUDA Health-$2.77M-$2.40N/AN/AN/AN/AN/AN/A7/28/2026 (Estimated)SERASera Prognostics-$31.93M-$0.65N/AN/AN/A-56,385.97%-41.02%-30.95%8/5/2026 (Estimated)Latest CCM, SERA, DCGO, and EUDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/11/2026Q1 2026DCGODocGo-$0.02-$0.12-$0.10-$0.15$72.48 million$75.55 million5/6/2026Q1 2026SERASera Prognostics-$0.16-$0.17-$0.01-$0.17$0.07 million$0.01 million5/5/2026Q4 2025EUDAEUDA Health-$1.20-$0.44+$0.76-$0.44$3.90 million$1.92 million4/29/2026Q4 2025CCMConcord Medical ServicesN/A-$1.08N/A-$1.08N/AN/A3/18/2026Q4 2025SERASera Prognostics-$0.17-$0.16+$0.01-$0.16$0.03 million$0.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCCMConcord Medical ServicesN/AN/AN/AN/AN/ADCGODocGoN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCCMConcord Medical Services1.330.480.46DCGODocGoN/A1.791.79EUDAEUDA HealthN/A0.180.18SERASera PrognosticsN/A2.122.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCCMConcord Medical ServicesN/ADCGODocGo56.44%EUDAEUDA Health4.35%SERASera Prognostics54.64%Insider OwnershipCompanyInsider OwnershipCCMConcord Medical Services46.50%DCGODocGo3.80%EUDAEUDA HealthN/ASERASera Prognostics11.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCCMConcord Medical Services9704.34 million2.32 millionNot OptionableDCGODocGo3,56898.75 million95.00 millionOptionableEUDAEUDA Health22.99 millionN/ANot OptionableSERASera Prognostics12039.16 million34.73 millionOptionableCCM, SERA, DCGO, and EUDA HeadlinesRecent News About These CompaniesSera Prognostics Holds 2026 Annual Stockholders MeetingJune 4 at 7:10 PM | tipranks.comSERA PROGNOSTICS ANNOUNCES BOARD TRANSITIONJune 1, 2026 | prnewswire.comSera Prognostics (NASDAQ:SERA) Shares Down 2.3% - Here's WhyMay 29, 2026 | americanbankingnews.comSera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerMay 14, 2026 | zacks.comSera Prognostics, Inc.: Sera Prognostics Reports First Quarter 2026 Financial ResultsMay 9, 2026 | finanznachrichten.deWill Sera Prognostics (NASDAQ:SERA) Spend Its Cash Wisely?May 8, 2026 | finance.yahoo.comSera Prognostics Balances Cash Strength With Slow RampMay 7, 2026 | tipranks.comSera Prognostics, Inc. (SERA) Q1 2026 Earnings Call TranscriptMay 7, 2026 | seekingalpha.comSera Prognostics Q1 Earnings Call HighlightsMay 7, 2026 | marketbeat.comSera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPSMay 6, 2026 | marketbeat.comSera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue EstimatesMay 6, 2026 | zacks.comSERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSMay 6, 2026 | prnewswire.comSERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026April 22, 2026 | prnewswire.comSera Prognostics Inc.April 11, 2026 | barrons.comSera Prognostics (SERA) Upgraded to Buy: What Does It Mean for the Stock?March 31, 2026 | zacks.com5 Top-Ranked Stocks With Rising P/E That Investors Can Bet OnMarch 31, 2026 | zacks.comSera Prognostics, Inc. (NASDAQ:SERA) Q4 2025 earnings call transcriptMarch 20, 2026 | msn.comSera Prognostics Earnings Call: Data-Rich, Revenue-LightMarch 19, 2026 | tipranks.comSera Prognostics, Inc.: Sera Prognostics Reports Fourth Quarter And Full Year 2025 Financial ResultsMarch 19, 2026 | finanznachrichten.deSera Prognostics Inc (SERA) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges and ...March 19, 2026 | uk.finance.yahoo.comSera Prognostics Sets Stage for Commercial Success with Strong 2025 PerformanceMarch 19, 2026 | news.themarketisopen.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCCM, SERA, DCGO, and EUDA Company DescriptionsConcord Medical Services NYSE:CCM$4.74 -0.32 (-6.40%) Closing price 03:59 PM EasternExtended Trading$4.81 +0.07 (+1.48%) As of 04:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.DocGo NASDAQ:DCGO$0.56 -0.01 (-1.91%) Closing price 04:00 PM EasternExtended Trading$0.57 +0.01 (+1.57%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.EUDA Health NASDAQ:EUDA$16.06 -0.25 (-1.53%) Closing price 04:00 PM EasternExtended Trading$16.00 -0.06 (-0.37%) As of 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.Sera Prognostics NASDAQ:SERA$2.29 +0.05 (+2.23%) Closing price 04:00 PM EasternExtended Trading$2.26 -0.03 (-1.27%) As of 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Buy the Dip? Broadcom's AI Moat Is Wider Than Ever The Market Has Ollie’s Bargain Outlet Completely Wrong Broadcom's Whiplash: Shares Tank After Pre-Earnings Surge Navitas: NVIDIA’s AI Power Broker? Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious NVIDIA's New Power Play: Why Fluence Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
